Q885K0 Acetylornithine aminotransferase 1 MolNFT, Molecular NFT on GenesisL1

Acetylornithine aminotransferase 1

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeibjadaqy7gouvlawqrnbdzxkayja32yj4yryqsp6kyphkrzcfm6im/metadata.json

IPFS of structure file:

bafybeidp3mt3j2xegu4pmelailzgmfsw5o7fdukwllya6hbg5omue62zkm/AF-Q885K0-F1-model_v2.pdb

First NFT owner address (eip-55):

0x2a3759A4E6DC4baB273edE849e13ebCabc51A0b3

First NFT owner address (bech32):

genesis19gm4nf8xm396kfe7m6zfuylte279rg9nrw0dqg

Current NFT ID #21730 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
21730
Accession (UniProt):
Q885K0
Name::
Acetylornithine aminotransferase 1
Experimental Method:
Predicted structure
Sequence source:
PSEUDOMONAS SYRINGAE PV. TOMATO (STRAIN ATCC BAA-871 / DC3000)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q885K0 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q885K0|ARGD1_PSESM Acetylornithine aminotransferase 1 OS=Pseudomonas syringae pv. tomato (strain ATCC BAA-871 / DC3000) OX=223283 GN=argD1 PE=3 SV=1 MSVEHAAVQRADFDQVMVPNYAPAGFIPVRGAGSRVWDQAGRELVDFSGGIAVNVLGHCHPALVGALTEQANNLWHVSNVFTNEPTLRLAKKLVDSTFAERVFFCNSGAEANEAAFKLARRVAHDLYGPEKYEIIAAVNSFHGRTLFTVSVGGQPKYSDGFGPKITGISHVPYNDLEALKAAVTDKTCAVVLEPIQGEGGVLPGELDYLQGARKLCDEHNALLVFDEVQSGMGRSGHLFAYMHYGVTPDILSSAKSIGGGFPLAAMLTTEKLAKHFAVGVHGTTYGGNPLACAVGEAVIDVINTPEVLAGVQRKHQQFKTRLESIGQQYGVFTEVRGLGLLIGCVLSDAWKGKAKDIFNAAEAQDLMILQAGPDVIRFAPSLVIEDADIEEGLNRFERAIAKLTS

Q885K0 AF NFT

MOLNFT AF v1

NFT data

MOLNFT Q885K0 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience